The UK hypodermic syringes and needles market size is anticipated to reach USD 479.3 million by 2030, expanding at a CAGR of 16.2% from 2024 to 2030. The growth can be attributed to factors such as the growing geriatric population, increasing prevalence of chronic disorders, and rising number of surgeries. Increasing demand for syringes for mass vaccination is the primary factor driving the demand for hypodermic syringes and needles. Moreover, an increasing number of needlestick injuries is expected to drive the market growth. According to a National Library of Medicine study published in April 2024, approximately 100,000 needlestick injuries occur annually in the UK.
Furthermore, enhancing the efficacy and safety of anesthetic administration are the growing technological developments in syringes and needle designs. The market is expanding due to innovations, including safety-engineered syringes, ultra-thin needles, and smart syringes with integrated technology. These developments aid in patient comfort, improving accuracy and lowering problems, which makes it easier for patients to accept innovative products.
Furthermore, the need for hypodermic needles and syringes is fueled by the UK's advanced healthcare system, which is comprised of modern hospitals and clinics. Investments made to modernize and enlarge medical facilities result in higher use of these hypodermic syringes. The National Health Service (NHS) finances healthcare services, which makes it easier to buy hypodermic syringes, and other contemporary medical equipment.
UK regulations demand that hypodermic syringes and needles meet high standards for patient safety, sterility, and quality. Manufacturers must adhere to guidelines set by regulatory bodies such as the Medicines and Healthcare Products Regulatory Agency (MHRA) and European Medical Device Regulation (MDR), which increase the cost and complexity of the approval process. The process of obtaining approval for medical devices such as hypodermic syringes and needles can be time-consuming due to the need for clinical testing, safety evaluations, and risk assessments.
This product will be delivered within 1-3 business days.
Furthermore, enhancing the efficacy and safety of anesthetic administration are the growing technological developments in syringes and needle designs. The market is expanding due to innovations, including safety-engineered syringes, ultra-thin needles, and smart syringes with integrated technology. These developments aid in patient comfort, improving accuracy and lowering problems, which makes it easier for patients to accept innovative products.
Furthermore, the need for hypodermic needles and syringes is fueled by the UK's advanced healthcare system, which is comprised of modern hospitals and clinics. Investments made to modernize and enlarge medical facilities result in higher use of these hypodermic syringes. The National Health Service (NHS) finances healthcare services, which makes it easier to buy hypodermic syringes, and other contemporary medical equipment.
UK regulations demand that hypodermic syringes and needles meet high standards for patient safety, sterility, and quality. Manufacturers must adhere to guidelines set by regulatory bodies such as the Medicines and Healthcare Products Regulatory Agency (MHRA) and European Medical Device Regulation (MDR), which increase the cost and complexity of the approval process. The process of obtaining approval for medical devices such as hypodermic syringes and needles can be time-consuming due to the need for clinical testing, safety evaluations, and risk assessments.
UK Hypodermic Syringes And Needles Market Report Highlights
- Based on product, the hypodermic syringes segment held the largest market share in 2023. This is attributed to the quick technical developments that increase patient comfort, safety, and effectiveness during medical procedures
- Based on end use, the hospitals segment dominated the market with the largest revenue share in 2023. This is due to their crucial role in maintaining a consistent and high demand for hypodermic needles and syringes, primarily due to the extensive number of medical procedures carried out
The leading players in the UK Hypodermic Syringes and Needles market include:
- BD (Becton, Dickinson & Corporation)
- Cardinal Health
- B. Braun SE
- ICU Medical
- Terumo Corporation
- Nipro Europe Group Companies (Nipro Corporation)
- SolM
- GBUK Group Ltd.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. Product Business Analysis
Chapter 5. End Use Business Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players in the UK Hypodermic Syringes and Needles market include:- BD (Becton, Dickinson & Corporation)
- Cardinal Health
- B. Braun SE
- ICU Medical
- Terumo Corporation
- Nipro Europe Group Companies (Nipro Corporation)
- SolM
- GBUK Group Ltd.
Methodology
LOADING...
